COVID-19 rapid guideline: haematopoietic stem cell transplantation – guidance (NG164)

The purpose of this guideline is to maximise safety of patients who need haemopoietic stem cell transplantation and make the best use of resources, while protecting staff from infection. It will also enable services to match capacity to patient needs if services become limited.

Source:

National Institute for Health and Care Excellence